{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:10:48Z","timestamp":1778901048155,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vasdi.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:57:01Z","timestamp":1777319821000},"page":"155-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thalidomide for high-flow arteriovenous malformations: A case report and comprehensive literature review"],"prefix":"10.1016","volume":"51","author":[{"given":"Alexis","family":"Cardenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-3781","authenticated-orcid":false,"given":"Thomas","family":"Foret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Fournel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve","family":"Puzenat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vasdi.2026.04.001_bib0060","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms23042358","article-title":"ISSVA classification of vascular anomalies and molecular biology","volume":"23","author":"Kunimoto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3171\/foc.2001.11.5.2","article-title":"Epidemiology and natural history of arteriovenous malformations","volume":"11","author":"Stapf","year":"2001","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0070","first-page":"e113","article-title":"Updated classification of vascular anomalies. A living document from the International Society for the Study of Vascular Anomalies Classification Group","volume":"6","author":"Goldenberg","year":"2025","journal-title":"J Vasc Anom"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13023-024-03413-5","article-title":"Diagnosis and management of superficial arteriovenous malformations: French healthcare network's recommendations","volume":"20","author":"Boccara","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/hmg\/ddac169","article-title":"Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model","volume":"32","author":"Nguyen","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/STROKEAHA.117.020356","article-title":"Thalidomide reduces hemorrhage of brain arteriovenous malformations in a mouse model","volume":"49","author":"Zhu","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0090","doi-asserted-by":"crossref","first-page":"448","DOI":"10.23736\/S0392-9590.23.05111-8","article-title":"Early experience of thalidomide therapy for high-grade peripheral and facial arteriovenous malformations","volume":"42","author":"Nip","year":"2023","journal-title":"Int Angiol"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s44161-022-00080-2","article-title":"Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations","volume":"1","author":"Boon","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1160\/TH07-06-0396","article-title":"Concurrent thalidomide and radiation therapy for extensive arterio-venous malformations","volume":"99","author":"Blinc","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/cells14141081","article-title":"Modeling aberrant angiogenesis in arteriovenous malformations using endothelial cells and organoids for pharmacological treatment","volume":"14","author":"Oh","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.vasdi.2026.04.001_bib0110","doi-asserted-by":"crossref","first-page":"e172837","DOI":"10.1172\/JCI172837","article-title":"Extracranial arteriovenous malformations: towards etiology-based therapeutic management","volume":"135","author":"Coulie","year":"2025","journal-title":"J Clin Invest"}],"container-title":["Vascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050658126002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050658126002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:25:07Z","timestamp":1778898307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050658126002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3050658126002098"],"URL":"https:\/\/doi.org\/10.1016\/j.vasdi.2026.04.001","relation":{},"ISSN":["3050-6581"],"issn-type":[{"value":"3050-6581","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalidomide for high-flow arteriovenous malformations: A case report and comprehensive literature review","name":"articletitle","label":"Article Title"},{"value":"Vascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vasdi.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}